WILGO research guide

BPC-157 + TB-500

Combination peptide / tissue-repair research

Current source listing$109Current blend listing — $109

Current pricing/options were checked against the linked source catalog. Availability and pricing can change. This page does not provide dosing or human-use instructions.

Research-use context: “What it is used for” below means what scientists and clinical researchers have investigated—not an instruction or recommendation for personal use.

What researchers study

This combination brings together two experimental regenerative-research peptides. BPC-157 is studied in tendon, ligament, muscle and gastrointestinal models; TB-500 is related to thymosin-β4 research involving cell migration, angiogenesis and wound repair.

Potential side effects & unknowns

There is no robust human safety profile for the BPC-157/TB-500 combination. Combining two investigational compounds adds uncertainty because interaction effects, systemic exposure and long-term safety have not been established in controlled human trials.

Research highlight

Both compounds have produced encouraging tissue-repair signals in preclinical models. Thymosin-β4 itself has been studied topically in human wound-healing research, but that is not equivalent to proving efficacy or safety for injected TB-500 or for this combination.

Dr. Jones, DC: Doctor Explains What Peptides He Personally Takes And Why

Additional commentary from Dr. Dean Jones, DC. This video is embedded for context and education; WILGO does not control or independently verify claims made in third-party videos.

Video hosted by YouTube. Opening or playing it may be subject to YouTube's privacy terms.

Research references

PubMed: injectable peptide evidence review ↗ PubMed: thymosin β4 dermal healing ↗

Looking for BPC-157 + TB-500?

Follow the tracked WILGO product link to see current inventory, exact product specifications and checkout pricing.

View Current Product →